2005
DOI: 10.1091/mbc.e04-12-1056
|View full text |Cite
|
Sign up to set email alerts
|

Developmental Activation of the Rb–E2F Pathway and Establishment of Cell Cycle-regulated Cyclin-dependent Kinase Activity during Embryonic Stem Cell Differentiation

Abstract: To understand cell cycle control mechanisms in early development and how they change during differentiation, we used embryonic stem cells to model embryonic events. Our results demonstrate that as pluripotent cells differentiate, the length of G 1 phase increases substantially. At the molecular level, this is associated with a significant change in the size of active cyclin-dependent kinase (Cdk) complexes, the establishment of cell cycle-regulated Cdk2 activity and the activation of a functional Rb-E2F pathwa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
169
2

Year Published

2008
2008
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 148 publications
(178 citation statements)
references
References 57 publications
7
169
2
Order By: Relevance
“…In somatic cells, the transition from G1 to S-phase, which is followed by DNA synthesis, is initiated by CDK4 and CDK6 in conjunction with D-type cyclins, and is further propelled mainly by CDK2 complexed with cyclin E and cyclin A, with the key target of these CDKs being retinoblastoma protein (RB)/E2F-mediated transcriptional regulation [21]. In mouse ESCs, the RB/E2F pathway is constitutively activated, thus eliminating effective regulation of the G1/S transition [22][23][24]. In contrast, several lines of evidence published by four independent laboratories and unpublished data from our laboratory indicate that hESCs can modify CDK activity to promote and/or inhibit cell cycle progression.…”
Section: Discussionmentioning
confidence: 99%
“…In somatic cells, the transition from G1 to S-phase, which is followed by DNA synthesis, is initiated by CDK4 and CDK6 in conjunction with D-type cyclins, and is further propelled mainly by CDK2 complexed with cyclin E and cyclin A, with the key target of these CDKs being retinoblastoma protein (RB)/E2F-mediated transcriptional regulation [21]. In mouse ESCs, the RB/E2F pathway is constitutively activated, thus eliminating effective regulation of the G1/S transition [22][23][24]. In contrast, several lines of evidence published by four independent laboratories and unpublished data from our laboratory indicate that hESCs can modify CDK activity to promote and/or inhibit cell cycle progression.…”
Section: Discussionmentioning
confidence: 99%
“…Pluripotent cells of embryonic origin exhibit a short G 1 phase that is driven by precocious and unrestrained cyclin expression (12,26,34). Although differentiation is coupled with the upregulation of p21 Cip1 and p27 Kip1 (40), many of the mechanisms and factors underlying cell cycle maturation in early neurons are largely unknown. While a role for p53 has been proposed in these processes (26), our data show that Lif withdrawal results in a strong downregulation of p53 mRNA and protein expression.…”
Section: Discussionmentioning
confidence: 99%
“…As it turns out, in early development, the strict requirements for cell growth are suspended to allow rapid cell proliferation 38,39 and is activated again when ESCs are induced to differentiate into embryoid bodies. 40,41 A recent study, conducted by Mayshar et al 34 , identified a substantial number of hiPS cell lines carrying full and partial chromosomal aberrations. To conclude, both hESCs and hiPSCs should be tightly monitored regarding their genomic stability.…”
Section: Aneuploidy Screeningmentioning
confidence: 99%